1278905

Li Peng, Ph.D. — FEI 3030623661

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 31, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Shijiazhuang (China)

Additional Details

Clinical BA/BE